Inventor · disambiguated record
Arlindo L. Castelhano
Also filed as: CASTELHANO ARLINDO · CASTELHANO ARLINDO L · CASTELHANO ARLINDO LUCAS
49 granted patents·9 pending applications·1,050 citations·filing 1985–2022
98Inventor score
Top patents by PatentIndex Score
58 records- 0195US6680324B2Compounds specific to adenosine A1 receptors and uses thereofOSI PHARM INC·Filed 2001·Granted Jan 20, 2004·68 cites·37 claims
- 0295US6680322B2Compounds specific to adenosine A1 receptors and uses thereofOSI PHARM INC·Filed 2000·Granted Jan 20, 2004·67 cites·37 claims
- 0392US7485658B2N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitorsOSI PHARM INC·Filed 2004·Granted Feb 3, 2009·39 cites·5 claims
- 0492US6916804B2Pyrimidine A2b selective antagonist compounds, their synthesis and useOSI PHARM INC·Filed 2002·Granted Jul 12, 2005·45 cites·22 claims
- 0592US6143744ASulfamide-metalloprotease inhibitorsSYNTEX INC·Filed 1999·Granted Nov 7, 2000·55 cites·46 claims
- 0691US5998412ASulfamide-metalloprotease inhibitorsSYNTEX INC·Filed 1998·Granted Dec 7, 1999·52 cites·15 claims
- 0790US6376506B1Sulfamide-metalloprotease inhibitorsSYNTEX LLC·Filed 1999·Granted Apr 23, 2002·47 cites·5 claims
- 0889US6800633B2Pyrrolo[2,3d]pyrimidine compositions and their useOSI PHARM INC·Filed 2000·Granted Oct 5, 2004·29 cites·16 claims
- 0989US6673802B2Compounds specific to adenosine A3 receptor and uses thereofOSI PHARM INC·Filed 2001·Granted Jan 6, 2004·26 cites·16 claims
- 1088US7504407B2Compounds specific to adenosine A1 and A3 receptors and uses thereofOSI PHARM INC·Filed 2002·Granted Mar 17, 2009·29 cites·12 claims
- 1188US5932595AMatrix metalloprotease inhibitorsSYNTEX INC·Filed 1996·Granted Aug 3, 1999·88 cites·60 claims
- 1286US6664252B24-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereofOSI PHARM INC·Filed 2000·Granted Dec 16, 2003·28 cites·34 claims
- 1385US7160890B2Compounds specific to adenosine A3 receptor and uses thereofOSI PHARM INC·Filed 2000·Granted Jan 9, 2007·16 cites·46 claims
- 1485US6008243AMetalloproteinase inhibitors, pharmaceutical compositions containing them, and their useAGOURON PHARMA·Filed 1997·Granted Dec 28, 1999·70 cites·15 claims
- 1585US4970297ATransglutaminase inhibitorsSYNTEX INC·Filed 1987·Granted Nov 13, 1990·22 cites·22 claims
- 1683US7429574B24-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their useOSI PHARM INC·Filed 2004·Granted Sep 30, 2008·14 cites·8 claims
- 1783US6495699B2Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their useAGOURON PHARMA·Filed 2001·Granted Dec 17, 2002·11 cites·1 claims
- 1883US6130220ASulfamide-metalloprotease inhibitorsSYNTEX INC·Filed 1999·Granted Oct 10, 2000·30 cites·44 claims
- 1982US6949563B2(2-carboxamido)(3-amino)thiophene compoundsWYNNE GRAHAM MICHAEL·Filed 2004·Granted Sep 27, 2005·19 cites·16 claims
- 2082US4912120A3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitorsSYNTEX INC·Filed 1987·Granted Mar 27, 1990·55 cites·32 claims
- 2181US6878716B1Compounds specific to adenosine A1 receptor and uses thereofOSI PHARM INC·Filed 1999·Granted Apr 12, 2005·27 cites·35 claims
- 2281US4929630ATransglutaminase inhibitorsSYNTEX INC·Filed 1989·Granted May 29, 1990·49 cites·13 claims
- 2378US7262196B2Tri(cyclo) substituted amide glucokinase activator compoundsPROSIDION LTD·Filed 2004·Granted Aug 28, 2007·11 cites·17 claims
- 2476US7501407B2Pyrimidine A2B selective antagonist compounds, their synthesis and useOSI PHARM INC·Filed 2004·Granted Mar 10, 2009·8 cites·7 claims
- 2575US8557814B2mTOR inhibitor salt formsCASTELHANO ARLINDO L·Filed 2009·Granted Oct 15, 2013·4 cites·18 claims
- 2674US7521448B2N-substituted benzimidazolyl c-Kit inhibitorsOSI PHARM INC·Filed 2004·Granted Apr 21, 2009·9 cites·6 claims
- 2774US7439256B2(Arylamidoaryl) cyanoguanidine compoundsCASTELHANO ARLINDO·Filed 2005·Granted Oct 21, 2008·5 cites·8 claims
- 2873US7645754B2Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and useOSI PHARM INC·Filed 2007·Granted Jan 12, 2010·1 cites·10 claims
- 2973US7598252B2Compounds specific to adenosine A, receptors and uses thereofOSI PHARM INC·Filed 2003·Granted Oct 6, 2009·4 cites·6 claims
- 3073US6037472AMatrix metalloprotease inhibitorsSYNTEX INC·Filed 1994·Granted Mar 14, 2000·23 cites·15 claims
- 3170US12116359B2EBNA1 inhibitor crystalline forms, and methods of preparing and using sameTHE WISTAR INST·Filed 2022·Granted Oct 15, 2024·0 cites·10 claims
- 3269US6686366B1Compounds specific to adenosine A3 receptor and uses thereofOSI PHARM INC·Filed 1999·Granted Feb 3, 2004·32 cites·50 claims
- 3367US7662844B2Naphthylene derivatives as cytochrome P450 inhibitorsOSI PHARM INC·Filed 2004·Granted Feb 16, 2010·6 cites·33 claims
- 3467US7064122B2Pancreatic lipase inhibitor compounds, their synthesis and useOSI PHARM INC·Filed 2002·Granted Jun 20, 2006·3 cites·27 claims
- 3564US7442709B2N3-substituted imidazopyridine c-Kit inhibitorsOSI PHARM INC·Filed 2004·Granted Oct 28, 2008·2 cites·4 claims
- 3663US11242338B2EBNA1 inhibitor crystalline forms, and methods of preparing and using sameTHE WISTAR INST·Filed 2019·Granted Feb 8, 2022·0 cites·25 claims
- 3763US7767673B2N-substituted imidazopyridine c-Kit inhibitorsOSI PHARM INC·Filed 2008·Granted Aug 3, 2010·0 cites·8 claims
- 3862US2009082369A1Pyrrolo[2,3d]pyrimidine compositions and their useOSI PHARM INC·Filed 2008·Application pending·0 cites
- 3960US6376667B1Solid phase synthesis of heterocyclesOSI PHARM INC·Filed 1998·Granted Apr 23, 2002·7 cites·4 claims
- 4060US2008070936A1Compounds specific to adenosine A1 receptors and uses thereofOSI PHARM INC·Filed 2007·Application pending·0 cites
- 4159US6037340ASynthesis and use of thiophene- and pyrrole-based heteroaromatic compoundsOSI PHARM·Filed 1997·Granted Mar 14, 2000·9 cites·64 claims
- 4258US2009192177A12-ARYL pyrrologpyrimidines for A1 and A3 receptorsOSI PHARM INC·Filed 2008·Application pending·0 cites
- 4357US6638941B1Conformationallly constrained peptidomimetics as β-turn templates and modulators of SH3 domainsOSI PHARM INC·Filed 1998·Granted Oct 28, 2003·9 cites·24 claims
- 4456US4668703Aγ-allenyl-γ-aminobutyric acidsSYNTEX INC·Filed 1985·Granted May 26, 1987·4 cites·20 claims
- 4555US6013792AMatrix metalloprotease inhibitorsSYNTEX INC·Filed 1995·Granted Jan 11, 2000·12 cites·22 claims
- 4651US2003212067A1Matrix metalloprotease inhibitorsFiled 2003·Application pending·0 cites
- 4749US2003229067A1Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and useFiled 2002·Application pending·0 cites
- 4848US2007129547A1Process to prepare substituted imidazopyrazine compoundsMULVIHILL KRISTEN M·Filed 2006·Application pending·0 cites
- 4947US6306892B1Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their useAGOURON PHARMA·Filed 2000·Granted Oct 23, 2001·0 cites·20 claims
- 5044USH1992HMetalloproteinase inhibitors, pharmaceutical compositions containing them, and their pharmaceutical usesAGOURON PHARMA·Filed 1999·Granted Sep 4, 2001·2 cites·26 claims
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Arlindo L. Castelhano files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →